Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental.
Fiche publication
Date publication
août 2019
Journal
BMC psychiatry
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel
Tous les auteurs :
Bennabi D, Charpeaud T, Yrondi A, Genty JB, Destouches S, Lancrenon S, Alaïli N, Bellivier F, Bougerol T, Camus V, Dorey JM, Doumy O, Haesebaert F, Holtzmann J, Lançon C, Lefebvre M, Moliere F, Nieto I, Rabu C, Richieri R, Schmitt L, Stephan F, Vaiva G, Walter M, Leboyer M, El-Hage W, Llorca PM, Courtet P, Aouizerate B, Haffen E
Lien Pubmed
Résumé
Clear guidance for successive antidepressant pharmacological treatments for non-responders in major depression is not well established.
Mots clés
Antidepressants, Expert consensus guidelines, Major depressive disorder, Pharmacotherapy, Treatment resistant depression
Référence
BMC Psychiatry. 2019 Aug 28;19(1):262